About
Neuraly is a clinical-stage biotechnology company developing disease-modifying therapies for neurodegenerative diseases such as Parkinson's and Alzheimer's by inhibiting pathological glial activation to prevent neuronal cell death.
Explore Neuraly's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.